SK
About
Roy has over 16 years of computational drug discovery experience, including 10 years at Bristol-Myers Squibb in Connecticut, two years at Variagenics, a personalized medicine company formerly in Cambridge, MA, and most recently over three years at Schrodinger, Inc. where he was responsible for launching collaborative research projects with global pharmaceutical firms and top academic laboratories. Roy also previously served as Visiting Associate Professor at Tokyo Institute of Technology where he lectured in drug discovery and biotechnology entrepreneurship. Roy received his Ph.D. in biomedical engineering from Boston University, and completed his post-doctoral studies at MIT.
Investment Focus
- Location
- Tokyo, Japan
Contact Information
linkedin.com/in/••••••••
Find more investors like Suguru Roy
Search Investors